Cargando…
Understanding the barriers to using oral anticoagulants among long-term aspirin users with atrial fibrillation – a qualitative study
BACKGROUND: Despite international treatment guidelines currently advocating oral anticoagulants (OACs) as the only appropriate stroke prevention therapy for patients with atrial fibrillation (AF) and evidence that OACs can greatly reduce the risk of stroke with similar risk of bleeding compared with...
Autores principales: | Ng, Vanessa W. S., Siu, Chung-Wah, Chiu, Patrick K. C., Kng, Carolyn P. L., Jamieson, Elizabeth, Wong, Ian C. K., Lam, May P. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691100/ https://www.ncbi.nlm.nih.gov/pubmed/33238989 http://dx.doi.org/10.1186/s12913-020-05947-3 |
Ejemplares similares
-
Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014) -
Exploring barriers to optimal anticoagulation for atrial fibrillation: interviews with clinicians
por: Decker, Carole, et al.
Publicado: (2012) -
Efficacy and Safety of Oral Anticoagulants Versus Aspirin for Patients With Atrial Fibrillation: A Meta-Analysis
por: Zhang, Jing-Tao, et al.
Publicado: (2015) -
Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
por: Winkle, Roger A., et al.
Publicado: (2014) -
Aspirin Compared to Low Intensity Anticoagulation in Patients with Non-Valvular Atrial Fibrillation. A Systematic Review and Meta-Analysis
por: Vazquez, Fernando J., et al.
Publicado: (2015)